Combined formalinised, aluminium hydroxide gel adsorbed monovalent leukotoxin culture supernatant
of Pasteurella haemolytica type A 1 with inactivated infectious bovine rhinotracheitis and parainfluenza
type 3 virus for the control of respiratory infections in cattle.

At all times store the vaccine at a temperature of 4 °C to 8 °C in a refrigerator.
Do not use the vaccine after the expiry date printed on the bottle.

RECOMMENDATIONS FOR USE
In South Africa Pasteurella haemolytica and respiratory virus infections occur primarily in feedlot cattle
kept under intensive conditions as well as in young animals under extensive conditions on farms.
The pneumonic form of pasteurellosis in feedlot cattle is preceded by infections with infectious bovine
rhinotracheitis and parainfluenza type 3 virus and stress conditions. Cattle should, therefore, be immunised against infectious bovine rhinotracheitis, parainfluenza type 3 and pasteurellosis before they are introduced into feedlots.

WARNINGS
Do not slaughter animals for human consumption within 7 days of vaccination.
Vaccinate healthy animals only.
Keep out of reach of children, uninformed persons and animals.
Although this product has been extensively tested under a large variety of conditions, failure
thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary
advice and notify the registration holder.

DIRECTIONS FOR USE
Use only as directed.
Sterilise syringes and needles by boiling in water for at least 15 minutes. Do not use disinfectants or
methylated spirits for sterilising either syringes or needles. Use a separate needle for each animal.
Shake the bottle well before use. Avoid exposure to high temperatures and direct sunlight during
inoculation.
Depending on circumstances, animals may be immunised at any age from two weeks.
Animals which are inoculated for the first time must be given 2 injections with an interval of 4 weeks.
Thereafter a single booster injection should be given every 6 to 12 months. It is advisable to give this
injection approximately a month before the anticipated occurrence of the disease.

DOSAGE: 5 ml subcutaneously irrespective of age or body mass.

EFFECTS OF THE VACCINE
The vaccine causes no reaction. Pregnant and lactating animals may be inoculated.
Immunity develops approximately two weeks after inoculation and protection lasts for about 6 months
but, however, cannot be guaranteed in all animals.

PACKING
Available in bottles of 20 or 100 doses.